Review: DIRECT - HSBC Life Protector II Pay to Age 70 (With Accelerated CI Benefit)

As of July 2026, the DIRECT - HSBC Life Protector II Pay to Age 70 (With Accelerated CI Benefit) is a commission-free Direct Purchase Insurance (DPI) whole life plan offered by HSBC Life (Singapore). Designed for self-directed buyers, this product provides lifelong coverage with a cash value component, funded through premiums payable until age 70. The plan includes basic protection against death, terminal illness, and total permanent disability (TPD), alongside an optional accelerated Critical Illness (CI) benefit that covers 30 conditions defined under the LIA Version 2024 standards. As a participating policy, it offers non-guaranteed reversionary bonuses based on the performance of HSBC’s par fund, which has reported net investment returns of 5.99%, 1.16%, and 3.28% over 3, 5, and 10-year periods respectively.

How it compares

When evaluated against similar DPI whole life plans for a 35-year-old male non-smoker with $100,000 sum assured, the HSBC Life Protector II presents distinct cost and value trade-offs.

Premium Costs: The annual premium for this product is $1,863, which is the lowest among its direct peers in this comparison. It is approximately $115 cheaper than the DIRECT- ManuAssure Life 70 ($1,978) and roughly $200 less than the DIRECT - GREAT Life II 85 ($2,029). However, it is significantly more affordable than the DIRECT - China Life Whole Life Plan, which requires a premium of $2,219 due to its longer payment term (to age 85).

Surrender Value and Returns: At year 20, the projected surrender value for the HSBC plan is $28,618. This figure is notably higher than both the ManuAssure Life 70 ($12,600) and the China Life Whole Life Plan ($17,630). It is also slightly higher than the Great Eastern option ($25,000), despite Great Eastern’s longer premium term.

Regarding efficiency, the HSBC plan carries a Total Expense Ratio (TER) of 1.88% at the 5-year mark. This is more cost-efficient than China Life (3.31%) and ManuAssure (2.40%), though slightly higher than Great Eastern’s 1.54%. In terms of long-term performance, the HSBC plan shows a 10-year net return of 3.28%, which is competitive compared to Great Eastern’s 3.68%, but lower than China Life’s 5-year return of 2.36% (note: direct 10-year comparison for China Life is not provided in the data).

Key Limitations: Unlike some competitors, this plan does not allow SRS or CPFIS premium payments. It also lacks a Sum Assured Multiplier feature and Guaranteed Insurable Options. The maximum sum assured for this specific DPI product is capped at $200,000 per life, whereas the general DPI cap for HSBC is $400,000.

Pros

• Lowest Premium: Offers the most affordable entry cost among comparable peers for a similar coverage structure.
• Strong Early Cash Value: Demonstrates a robust surrender value at year 20 ($28,618), outperforming ManuAssure and China Life significantly.
• Competitive Expense Ratio: A TER of 1.88% is relatively efficient compared to the broader market average for these specific products.
• Comprehensive CI Coverage: Includes an optional accelerated CI benefit covering 30 standard severe illnesses, providing early financial support upon diagnosis.

Cons

• No SRS/CPFIS Usage: Premiums must be paid via cash or bank transfer; retirement savings accounts cannot be used.
• Non-Guaranteed Returns: The cash value growth relies on non-guaranteed bonuses. While the illustrated yield is 1.60%–2.71%, actual returns depend on fund performance.
• Limited Sum Assured Cap: Capped at $200,000 for this specific plan, which may be insufficient for high-net-worth individuals seeking maximum direct purchase coverage.
• No Guaranteed Insurability: Policyholders cannot guarantee future insurability without further underwriting if their health changes.

Who it may suit

This product is best suited for cost-conscious consumers who prefer a lower annual premium burden and are comfortable with self-directing their insurance purchases. It may appeal to individuals who prioritize immediate cash value accumulation in the medium term (e.g., years 10–20) over ultra-long-term premium payment flexibility (like paying to age 85). It is less suitable for those wishing to utilize SRS/CPFIS funds or those requiring guaranteed insurability options.

This is general information based on CompareFIRST.sg data, not financial advice. Premiums and features can change; please verify with the insurer or a MAS-licensed financial adviser before making any decision.